Bartonella: important infection, complicated “tick-borne” claim
Bartonella is a genus of bacteria that can cause several distinct human diseases. The most important fact for a tick-focused website is this: CDC currently states there is no evidence showing Bartonella is spread to people through tick bites. A tick PCR finding is not the same thing as proven vector transmission.

Bartonellosis is not one single syndrome.
More than 20 Bartonella species are known, and several can infect humans. The best-established human pathogens include B. henselae, associated with cat-scratch disease; B. quintana, associated with trench fever, chronic bacteremia and endocarditis; and B. bacilliformis, which causes Carrion's disease in parts of South America. Other species have been linked to bacteremia, endocarditis and ocular or vascular manifestations.
These are fastidious Gram-negative bacteria with unusual relationships to mammalian hosts. Some species can establish bloodstream infection and interact with red blood cells and endothelial cells. Clinical disease depends heavily on the species and the immune status of the host. In immunocompromised people, B. henselae and B. quintana can cause vasoproliferative disease such as bacillary angiomatosis.
What is proven—and what is not
CDC's 2026 Bartonella overview identifies established routes that include fleas and flea-associated cat exposure for B. henselae, human body lice for B. quintana, and sand flies for B. bacilliformis. For cat-scratch disease, infection usually follows a scratch from a cat—often a kitten—when the claws are contaminated with flea feces carrying B. henselae. CDC Bartonella overview ↗
This matters when interpreting a tick-testing result. If a tick laboratory reports Bartonella DNA, the most accurate wording is: “Bartonella genetic material was detected in the tick.” It is not scientifically justified to turn that result into “the tick transmitted Bartonella to the person.”
The presentation depends on the species.
Bartonella henselae / cat-scratch disease
Typical cat-scratch disease often begins with a small papule or pustule at the inoculation site and is followed by tender regional lymph-node enlargement, sometimes with low-grade fever, fatigue and malaise. Most uncomplicated disease is self-limited. Less common complications can involve the eye, nervous system, liver, spleen, bone or heart. CDC cat-scratch disease ↗
Bartonella quintana
B. quintana can cause relapsing fever (“trench fever”), headache and characteristic bone pain, but it can also cause persistent bacteremia and culture-negative endocarditis. People living in crowded conditions with body-louse exposure are at increased risk.
Endocarditis and disseminated disease
Bartonella is an important cause of blood-culture-negative endocarditis. Persistent fever, a new murmur, embolic phenomena or compatible echocardiographic findings can prompt specialized serology and molecular testing.
No single Bartonella test answers every clinical question.
Diagnosis depends on the syndrome. Typical cat-scratch disease can sometimes be diagnosed clinically from exposure plus characteristic lymphadenopathy. Serology can support some diagnoses, but antibody cross-reactivity and persistence complicate interpretation. Culture is difficult because Bartonella are slow-growing and fastidious. PCR can be useful when the right specimen is available, including tissue, blood or cardiac-valve material in selected settings.
A negative test does not always exclude infection, and a positive antibody test does not by itself prove that nonspecific chronic symptoms are caused by Bartonella. The pretest clinical picture matters.
Treatment is species- and syndrome-specific.
Uncomplicated cat-scratch disease in immunocompetent people frequently resolves without antimicrobial therapy; CDC notes that antibiotics may reduce symptom duration in some cases. More serious manifestations—including neuroretinitis, bacillary angiomatosis, persistent bacteremia and endocarditis—require clinician-directed antibiotic treatment. Regimens often use agents such as doxycycline, rifampin, macrolides or aminoglycosides in specific combinations depending on the syndrome. Bartonella endocarditis is not something to self-treat from an internet protocol.
The distinction is important: “Bartonella” is not one disease with one universal regimen. CDC clinical overview ↗
There is direct laboratory research—but not human proof.
A 2019 peer-reviewed study screened 149 essential oils against stationary-phase Bartonella henselae in vitro. Oregano, cinnamon bark, mountain savory, clove, allspice, geranium, citronella and several other oils showed activity in the culture system. Carvacrol (a major oregano component) and cinnamaldehyde (a major cinnamon component) were among the most active isolated constituents. Read the study ↗
The investigators were explicit about the next steps: intracellular models, pharmacokinetics, animal studies and safety/efficacy studies were still needed. B. henselae can live in protected cellular niches, so killing free bacteria in a laboratory culture does not show that swallowing or applying an essential oil will safely treat human infection.
Some integrative protocols also use herbs such as Japanese knotweed, cryptolepis, cat's claw, Chinese skullcap or houttuynia for people labeled as having Bartonella. At present, those protocols should be described as traditional/integrative or anecdotal use unless a Bartonella-specific experiment is cited. A result from Lyme or Babesia cannot be assumed to apply to Bartonella simply because the same herb appears in multiple integrative protocols.
Key sources
Current transmission routes and explicit statement that human tick transmission is not established.
Read source ↗B. henselae exposure and clinical description.
Read source ↗Critical review of evidence for and against tick transmission of Bartonella.
Read source ↗In-vitro essential-oil screen against stationary-phase B. henselae.
Read source ↗Persistent fever, signs of endocarditis, severe neurologic symptoms, significant eye symptoms or systemic illness need medical evaluation. Bartonella syndromes vary by species and host factors.
Products worth knowing about
Cryptolepis and artemisinin are the two products I personally used during my Babesia experience. I am sharing what I used, not prescribing a treatment. The other items are practical support products people may find useful while keeping track of medications, supplements, and hydration.
What I personally used
Cryptolepis sanguinolenta
The Cryptolepis product I personally used. See the Cryptolepis page for the research, limitations, and my experience.
View Cryptolepis on Amazon
What I personally used
Artemisinin
The artemisinin product I personally used. See the Artemisinin page for the research, limitations, and my experience.
View Artemisinin on Amazon
Practical support
Large weekly pill organizer
A simple way to keep prescriptions and supplements organized when a routine gets complicated.
View pill organizer on Amazon
Practical support
Hydration / electrolyte packets
Convenient hydration support for people who want an easy electrolyte option. This is not a Babesia treatment.
View hydration packets on Amazon